Modified CHROMagar acinetobacter medium for direct detection of multidrug-resistant acinetobacter strains in nasal and rectal swab samples

Annals of Laboratory Medicine

Volumn 33, Issue 3, 2013, Pages 193-195

  Song, Wonkeun ^a   Lee, Jacob ^a   Kim, Taek Kyung ^b   Park, Min Jeong ^a   Kim, Han Sung ^a   Kim, Jae Seok ^a  

^a Hallym University College of Medicine   (South Korea)

^b Kangnam Sacred Heart Hospital   (South Korea)

Author keywords

Modified CHROMagar Acinetobacter; Multidrug resistant Acinetobacter spp; Nasal swab; Rectal swab

Indexed keywords

ANTIINFECTIVE AGENT; DIAGNOSTIC KIT;

ACINETOBACTER; ACINETOBACTER INFECTIONS; DIAGNOSTIC KIT; DRUG EFFECTS; EVALUATION STUDY; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; NOSE; RECTUM;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; NOSE; REAGENT KITS, DIAGNOSTIC; RECTUM;

EID: 84877961875     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2013.33.3.193     Document Type: Article

References (14)

1. Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007;59:525-30.
2. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden H, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007;13:97-103.
3. Wareham DM, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, et al. Bloodstream infection due to Acinetobacter spp.: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008;27:607-12.
4. Agustí C, Pujol M, Argerich MJ, Ayats J, Badía M, Domínguez MA, et al. Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 2002; 49:205-8.
5. Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 2005;55: 115-8.
6. Kohlenberg A, Brümmer S, Higgins PG, Sohr D, Piening BC, de Grahl C, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in Germany university medical centre. J Med Microbiol 2009;58:1499-507.
7. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006;50:2941-5.
8. Maragakis LL and Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46: 1254-63.
9. Gordon NC and Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol 2009; 47:2249-51.
10. Akers KS, Barsoumian A, Beckius ML, Murray CK, Mende K. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-clacoaceticus complex. Diagn Microbiol Infect Dis 2010;67:209-11.
11. Ajao AO, Robinson G, Lee MS, Ranke TD, Venezia RA, Furuno JP, et al. Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients. Eur J Clin Microbiol Infect Dis 2011;30:1425-30.
12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 22nd informational supplement, M100-S22. Wayne, PA: CLSI, 2012.
13. Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 1997;37:287-95.
14. Wareham DW and Gordon NC. Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii. J Clin Pathol 2011;64:164-7.